Global Veterinary Intravenous (IV) Solutions Market Size study, by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Regional Forecasts 2022-2032

The Global Veterinary Intravenous (IV) Solutions Market is valued approximately at USD 0.75 billion in 2023 and is anticipated to expand at a compound annual growth rate of 8.37% during the forecast period from 2024 to 2032. Veterinary IV solutions have emerged as a critical cornerstone in modern animal health management, enabling rapid rehydration, fluid therapy, and nutritional support across both production and companion animal populations. These solutions are pivotal in stabilizing critical care patients, aiding in post-operative recovery, and managing infectious or metabolic diseases, thereby driving their increasing adoption across veterinary hospitals, mobile clinics, and research institutions.

The market is being propelled by multiple converging factors, including the rising prevalence of chronic conditions such as kidney disease, parvovirus, and electrolyte imbalance in pets, along with the rapid intensification of livestock farming that often exposes animals to environmental and nutritional stress. Advances in veterinary diagnostics have enabled early detection of dehydration and systemic infections, thereby necessitating timely intravenous interventions. Moreover, the global push toward enhancing animal welfare, especially in developed markets, has encouraged pet owners and producers alike to invest in quality veterinary care—driving the demand for sterile, customizable IV fluid formulations.

The technological evolution of IV solutions—such as electrolyte-balanced fluids, dextrose infusions, and amino acid-enriched therapies—combined with portable IV delivery devices, is broadening the clinical applications and usability across diverse animal species and field settings. Leading players are also focusing on producing species-specific formulations that reduce adverse reactions and enhance absorption rates. Furthermore, growing awareness of zoonotic risk mitigation and increasing collaborations between veterinary pharmaceutical firms and livestock producers have strengthened supply chain efficiency, making these lifesaving fluids more accessible in remote and rural areas.

Regionally, North America leads the global market, supported by well-established veterinary infrastructure, high pet ownership rates, and comprehensive pet insurance coverage. Europe maintains a strong position with robust veterinary guidelines and animal welfare legislation. However, the Asia Pacific region is anticipated to register the fastest growth over the forecast horizon. Factors such as growing disposable income, rising investments in animal healthcare, and a burgeoning livestock sector in countries like India, China, and Indonesia are playing pivotal roles in the region’s expansion. Meanwhile, Latin America and the Middle East & Africa are expected to gradually gain momentum through increased government-led animal health initiatives and awareness campaigns on sustainable livestock management.

Major market player included in this report are:
• Zoetis Inc.
• Dechra Pharmaceuticals PLC
• Vetoquinol S.A.
• B. Braun Melsungen AG
• Norbrook Laboratories
• ICU Medical, Inc.
• Bayer Animal Health
• Virbac
• Henry Schein, Inc.
• Bimeda Inc.
• Orion Corporation
• Neogen Corporation
• Elanco Animal Health Incorporated
• Fresenius Kabi AG
• Ceva Santé Animale

The detailed segments and sub-segment of the market are explained below:

By Product
• Crystalloids
• Colloids
• Additive Solutions

By Animal Type
• Companion Animals
• Production Animals

By Indication
• Dehydration
• Electrolyte Imbalance
• Nutritional Deficiencies
• Drug Delivery
• Others

By End-use
• Veterinary Hospitals & Clinics
• Homecare Settings
• Research & Academic Institutes

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of MEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.